Amarin PLC Company Leadership
| AMRN Stock | USD 0.63 0.01 1.56% |
Amarin PLC employs about 275 people. The company is managed by 16 executives with a total tenure of roughly 7 years, averaging almost 0.0 years of service per executive, having 17.19 employees per reported executive. Analysis of Amarin PLC's management performance can provide insight into the firm performance.
| Aaron Berg President Senior Vice President - Marketing and Sales |
Amarin |
Amarin PLC Management Team Effectiveness
The company has return on total asset (ROA) of (0.0345) % which means that it has lost $0.0345 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0726) %, meaning that it created substantial loss on money invested by shareholders. Amarin PLC's management efficiency ratios could be used to measure how well Amarin PLC manages its routine affairs as well as how well it operates its assets and liabilities.Amarin PLC Workforce Comparison
Amarin PLC is rated below average in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 660,915. Amarin PLC adds roughly 275 in number of employees claiming only tiny portion of equities under Health Care industry.
The company has Profit Margin (PM) of (0.16) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.59) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.59. Amarin PLC Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Amarin PLC insiders, such as employees or executives, is commonly permitted as long as it does not rely on Amarin PLC's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Amarin PLC insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Steven Ketchum over a week ago Acquisition by Steven Ketchum of 663878 shares of Amarin PLC at 0.62 subject to Rule 16b-3 | ||
Patrick Holt over a month ago Acquisition by Patrick Holt of 958 shares of Amarin PLC at 1.025 subject to Rule 16b-3 | ||
Peter Fishman over a month ago Insider Trading | ||
Aaron Berg over a month ago Disposition of 29133 shares by Aaron Berg of Amarin PLC subject to Rule 16b-3 | ||
Peter Fishman over two months ago Insider Trading | ||
Aaron Berg over three months ago Acquisition by Aaron Berg of 160000 shares of Amarin PLC at 0.64 subject to Rule 16b-3 | ||
Dipaolo Mark over six months ago Acquisition by Dipaolo Mark of 179795 shares of Amarin PLC at 0.87 subject to Rule 16b-3 | ||
Thomas Reilly over six months ago Disposition of 16667 shares by Thomas Reilly of Amarin PLC subject to Rule 16b-3 |
Amarin PLC Notable Stakeholders
An Amarin PLC stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Amarin PLC often face trade-offs trying to please all of them. Amarin PLC's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Amarin PLC's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Patrick Holt | CEO President | Profile | |
| Aaron Berg | Senior Vice President - Marketing and Sales | Profile | |
| Laurent Abuaf | President VP | Profile | |
| Steven Ketchum | President Officer | Profile | |
| Jason JD | Chief VP | Profile | |
| Joseph JD | Exec Counsel | Profile | |
| Jordan Zwick | Senior Relations | Profile | |
| Alina Kolomeyer | Director Communications | Profile | |
| Nabil Abadir | Chief Affairs | Profile | |
| David Keenan | Executive Europe | Profile | |
| Peter Fishman | Chief Officer | Profile | |
| Jonathan Provoost | Executive Officer | Profile | |
| Donna Pasek | Senior Resources | Profile | |
| Karim Mikhail | CEO Pres | Profile | |
| Thomas Reilly | Chief Officer | Profile | |
| Lisa DeFrancesco | Sr Relations | Profile |
About Amarin PLC Management Performance
The success or failure of an entity such as Amarin PLC often depends on how effective the management is. Amarin PLC management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Amarin management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Amarin management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland. Amarin Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 560 people.
Amarin PLC Workforce Analysis
Traditionally, organizations such as Amarin PLC use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Amarin PLC within its industry.Amarin PLC Manpower Efficiency
Return on Amarin PLC Manpower
| Revenue Per Employee | 1.1M | |
| Revenue Per Executive | 19.2M | |
| Net Loss Per Employee | 215K | |
| Net Loss Per Executive | 3.7M | |
| Working Capital Per Employee | 1.7M | |
| Working Capital Per Executive | 29.1M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amarin PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Amarin Stock, please use our How to Invest in Amarin PLC guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amarin PLC. If investors know Amarin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amarin PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Amarin PLC is measured differently than its book value, which is the value of Amarin that is recorded on the company's balance sheet. Investors also form their own opinion of Amarin PLC's value that differs from its market value or its book value, called intrinsic value, which is Amarin PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amarin PLC's market value can be influenced by many factors that don't directly affect Amarin PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amarin PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amarin PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amarin PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.